Table 2.
All ACTG studies | Excluding substudies | ||
Parameters | Effect (95% CI) | Effect (95% CI) | |
AR1 | 0.04 (-0.37, 0.46) | -0.09 (-0.51, 0.33) | |
Time trend effect | 29.7 (18.9, 40.5) ‡ | 12.8 (3.9, 21.7) § | |
(per quarter) | |||
Large studies effect *(per point weight) | 699.7 (535.5, 864.0) ‡ | 420.3 (284.2, 556.4) ‡ | |
Early starting effect † | -83.3 (-427.3, 260.7) | -436.7 (-731.1,-142.2) § | |
Studies starting in same quarter (per study) | 20.6 (-1.4, 42.5) | -1.0 (-23.5, 21.4) | |
Seasonal effect | |||
Spring | 152.7 (-78.8, 406.2) | 189.3 (-32.4, 410.9) | |
Summer | 185.3 (-43.2, 413.7) | 115.3 (-90.6, 321.2) | |
Fall | -144.5 (-365.2, 76.2) | -96.7 (-308.8, 115.4) | |
Constant | 137.5 (-152.2, 427.2) | 576.5 (309.3, 843.7) ‡ |
ACTG: AIDS Clinical Trials Group, AR1: First-order autoregressive parameter * Sum of weights for large studies in each quarter: ½ for a large study which is initiated in that quarter, 1 for a large study which is on its second quarter of enrollment, and ½ for a large study which is on its third quarter of enrollment. † Dummy variable for first 3 quarters (Fall 1986-Spring 1987) ‡ p < 0.001 §0.001 ≤ p < 0.05